Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...

CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or refractory multiple myeloma who have previously received at least one line of ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

(Alliance News) - GSK PLC on Monday said it has submitted a US regulatory application for the expanded use of its Arexvy respiratory syncytial virus vaccine. The London-based drug maker said the ...

View this 3 bedroom, 2 bathroom rental house at 103 Binney Street, Euroa VIC 3666. Available from Wednesday, 09 July 2025. Contact agent for price.

Jane Street allegedly manipulated indices by using ‘pump-dump’ tactics and expiry day trades to profit from options trading.